Abstract
We read with interest the Correspondences from Stella O’Malley and colleagues1 and Richard Armitage2 on the use of puberty blockers for transgender and gender diverse (trans) young people, and wish to address several of their comments, which we view as problematic.
Original language | English |
---|---|
Pages (from-to) | e35-e36 |
Number of pages | 2 |
Journal | The Lancet Child and Adolescent Health |
Volume | 5 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2021 |
Keywords
- trans young people
- puberty blockers
- Adolescent Health